GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Solvonis Therapeutics PLC (LSE:SVNS) » Definitions » Book Value per Share

Solvonis Therapeutics (LSE:SVNS) Book Value per Share : £0.01 (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Solvonis Therapeutics Book Value per Share?

Solvonis Therapeutics's book value per share for the quarter that ended in Jun. 2024 was £0.01.

During the past 12 months, Solvonis Therapeutics's average Book Value Per Share Growth Rate was -60.60% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 5.90% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -0.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Solvonis Therapeutics was 26.00% per year. The lowest was -24.60% per year. And the median was 5.90% per year.

Solvonis Therapeutics's current price is £0.00165. Its book value per share for the quarter that ended in Jun. 2024 was £0.01. Hence, today's PB Ratio of Solvonis Therapeutics is 0.09.

During the past 6 years, the highest P/B Ratio of Solvonis Therapeutics was 18.33. The lowest was 0.06. And the median was 0.53.


Solvonis Therapeutics Book Value per Share Historical Data

The historical data trend for Solvonis Therapeutics's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solvonis Therapeutics Book Value per Share Chart

Solvonis Therapeutics Annual Data
Trend May18 May19 May20 May21 Dec22 Dec23
Book Value per Share
Get a 7-Day Free Trial 0.02 0.02 0.01 0.04 0.02

Solvonis Therapeutics Semi-Annual Data
May18 May19 May20 May21 Jun22 Dec22 Jun23 Dec23 Jun24
Book Value per Share Get a 7-Day Free Trial Premium Member Only 0.05 0.04 0.03 0.02 0.01

Competitive Comparison of Solvonis Therapeutics's Book Value per Share

For the Specialty Industrial Machinery subindustry, Solvonis Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solvonis Therapeutics's PB Ratio Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Solvonis Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Solvonis Therapeutics's PB Ratio falls into.



Solvonis Therapeutics Book Value per Share Calculation

Solvonis Therapeutics's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(2.03-0.00)/104.10
=0.02

Solvonis Therapeutics's Book Value Per Share for the quarter that ended in Jun. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(1.66-0.00)/124.76
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Solvonis Therapeutics  (LSE:SVNS) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Solvonis Therapeutics Book Value per Share Related Terms

Thank you for viewing the detailed overview of Solvonis Therapeutics's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Solvonis Therapeutics Business Description

Traded in Other Exchanges
Address
Eccleston Yards, 25 Eccleston Place, London, GBR, SW1W 9NF
Solvonis Therapeutics PLC, formerly Graft Polymer (UK) PLC focuses on the development of polymer modification and drug delivery systems. It has licensed its Drug Delivery System platform IP to MGC Pharmaceuticals in relation to MGC Pharma's CimetrA product. The group's products address customer needs across a wide range of end-use markets, from automotive through to medical, and are not dependent on one market segment. The Company operates in two business segments being polymer development and production in Slovenia.

Solvonis Therapeutics Headlines

No Headlines